Liang Qiao, MD, Chairman of the Board/ Chief Executive Officer

Dr. Qiao has over 20 years of medical research experience in the field of immunology at several leading universities with an emphasis on mucosal tolerance, immunity and vaccine development. He is a co-inventor of the technology on which our company's vaccines based on. He is also a tenured Associate Professor at the Stritch School of Medicine at Loyola University Chicago. His research projects at Loyola University Chicago have also been funded by National Institutes of Health, American Cancer Society, Cancer Research Institute, and Illinois Department of Health. Dr. Qiao received his M.D. from Lausanne University in Switzerland in 1992. He also worked as a Research Scholar at German Cancer Research Center. Dr. Qiao also serves as a reviewer for worldwide numerous scientific journals and funding agencies. In March 2008, he received a $1.8 million award from the NIH for a five-year research to develop a novel oral HIV vaccine through collaborations with research groups from UIC and Rush University.

Wenhui Qiao, President / Director

Mr. Qiao has extensive business experiences in China and Japan . He is also maintaining a good relationship with both the Chinese and Japanese business and political society. In 2002, he co-founded our wholly owned subsidiary, Bio-Bridge Science ( Beijing ) Corp., and served as CEO for Bio-Bridge Science, Inc.'s Chinese subsidiary. From 1999 to 2001, he was the CEO of Dongfang Huaying Anti-Radiation Company, a joint venture with Japanese to commercialize the environmental protection technology. Mr. Qiao graduated from Doshisha University in Japan with a BA degree in economics.

Chuen Huei (Kevin) Lee, CFA, FRM, Chief Financial Officer

Mr. Lee, CFA, FRM, is a former vice president of a venture capital investment & consulting firm. He specializes in corporate finance, international business management /business development, venture investment and financial management. He has ten years of experience in financial industry/banking and international business management field. He worked for American Express Bank and Grand Cathy Securities Corporation, one of Taiwan 's leading investment banking firm before joining the venture capital firm in Beijing,China. Mr. Lee graduated from Columbia University with an MBA degree and Taiwan University with a BA degree in Business Administration. He is a Chartered Financial Analyst and a Financial Risk Manager.

Isao Arimoto, Director

Mr. Arimoto is a co-founder of our company and has served as a director since our company's inception. He is currently Chief Executive Officer of Okayama-based Chugoko-Knit Co. Mr. Arimoto has over 30 years of business experience as an entrepreneur. He has extensive business relationship in both Japan and China .

Toshihiro Komoike, Director

Mr. Komoike has served as our director since October 2004. Mr. Komoike has 30 years of management experience. He was a senior manager at Sumisho Textile Co. in Japan , one of Japan 's leading textile companies. Before joining Sumisho, he was manager at Shinko Trading Company for over 10 years. He is a graduate of Kansai University with commerce major.

Shyh-Jing (Philip) Chiang, Director

Mr. Chiang is one of our co-founders and has served as our director since inception. Mr. Chiang also has served as director of Bio-Bridge (Cayman) Science Corporation since February 2002. Since June 2004, Mr. Chiang has served as head of investment banking at Nomura Securities in Taipei , Taiwan . From March 2004 to May 2004, he served as chief representative of Rabobank's office in Taipei . From June 2001 to May 2004, he was director of investment banking at ING Baring in Taipei . Mr. Chiang served as executive vice president of Grand Cathay Securities from August 2000 to June 2001. From September 1996 to April 2000, he served as vice president of Credit Agricole Indosuez. Mr. Chiang received a B.A. from Tunghai University in Taiwan and an M.B.A. from the University of Missouri .

Trevor Roy, Director

Mr. Roy was a graduate of the University of Sydney. His initial career was in Education where he was a teacher and administrator at both High School and Tertiary levels. Then in a business career spanning 30 years, Mr. Roy, with his investment and management experience, both in his home country of Australia and internationally, has been in a wide range of industries including Rural/agricultural, Theatrical, Marketing and Promotions, Food manufacturing and distribution, Medical, and Telephony and communications. For the past 18 years, Mr. Roy has been CEO (now Chairman) of the Creata Group of Companies. He has been instrumental in establishing its business as a global provider of marketing and promotional programs in 18 offices in 12 countries.

Mr. Cheung's early career was in Finance, Accounting and Auditing with John B P Byrne & Co., now Grant Thornton in Hong Kong. This formed the foundation of a successful business management and investment career over 25 years that now includes: ownership of manufacturing facilities in Hong Kong and China (Dongguan) with in excess of 10,000 employees producing over 200 million consumer products annually; ownership of a Class 2 hosipital in China (Fujian); and (commercial) real estate investments and developments in Hong Kong, China and the United States.